Market Overview

UPDATE: J&J Announces Acceptance of Binding Offer from Carlyle Group to Buy Ortho-Clinical Diagnostics for ~$4B

Related JNJ
Johnson & Johnson Announces Start of Safety and Immunogenicity Clinical Trial of Ebola Vaccine Regimen in Sierra Leone
Benzinga's M&A Chatter for Wednesday October 7, 2015
An Analysis Of Allergan (Seeking Alpha)

Johnson & Johnson (NYSE: JNJ) today announced that it has accepted the binding offer from The Carlyle Group, which was received and announced on January 16, 2014, to acquire its Ortho-Clinical Diagnostics business for approximately $4 Billion, subject to customary adjustments. This acceptance was made after consultation with the relevant works councils and trade unions. The transaction is expected to close toward the middle of the year, upon satisfaction of customary closing conditions.

Johnson & Johnson will discuss any updates during its scheduled quarterly earnings call on April 15, 2014.

Posted-In: News M&A


Related Articles (JNJ)

Get Benzinga's Newsletters